Other

Thereafter

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ1 2021
Last reportedQ1 2026May 1, 2026
Metric ID: other_finance_lease_liability_to_be_paid_after_year_four_f90688

Historical Data

15 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$600.00M$600.00M$1.11B$1.11B$1.11B$1.10B$1.10B$1.10B$1.07B$1.07B$1.07B$0.00$0.00$0.00$0.00
QoQ Change+0.0%+85.2%+0.0%+0.0%-1.3%+0.0%+0.0%-2.1%+0.0%+0.0%-100.0%
YoY Change+85.2%+85.2%-1.3%-1.3%-1.3%-2.1%-2.1%-2.1%-100.0%-100.0%-100.0%
Range$0.00$1.11B
CAGR-100.0%
Avg YoY Growth-12.7%
Median YoY Growth-2.1%

Frequently Asked Questions

What is Moderna's thereafter?
Moderna (MRNA) reported thereafter of $0.00 in Q1 2026.